Research output per year
Research output per year
Personal profile
Headline
Resident
Fingerprint
Dive into the research topics where Douglas Tremblay is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An overlooked mimic? Autoimmune myelofibrosis—A scoping review of the literature
Amel Riazat-Kesh, Y. J. R., Maraveyas, A., Martin, L. & Tremblay, D., 2023, (Accepted/In press) In: European Journal of Haematology.Research output: Contribution to journal › Article › peer-review
-
Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine
Feld, J., Tremblay, D., Navada, S. C. & Silverman, L. R., 2023, In: Leukemia and Lymphoma. 64, 3, p. 525-539 15 p.Research output: Contribution to journal › Review article › peer-review
-
CNL and aCML are prognostically distinct: a large National Cancer Database analysis
Tremblay, D., Sastow, D. & Mascarenhas, J., 16 Aug 2023, In: Blood advances. 7, 16, p. 4400-4402 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Emerging Treatment Options for Myelofibrosis: Focus on Anemia
Sastow, D. & Tremblay, D., 2023, In: Therapeutics and Clinical Risk Management. 19, p. 535-547 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Energy expenditure in myelofibrosis patients treated with a JAK1/2 inhibitor
Tremblay, D., Dougherty, M., Mascarenhas, J. & Gallagher, E. J., 2023, In: Frontiers in Endocrinology. 14, 1141029.Research output: Contribution to journal › Short survey › peer-review
Open Access
Press/Media
-
Dr Tremblay on the Identification and Prevalence of MDS/MPN Overlap Syndromes
10/11/23
1 item of Media coverage
Press/Media
-
Researchers from Icahn School of Medicine at Mount Sinai Discuss Findings in Acute Myeloid Leukemia (Exclusion of Acute Myeloid Leukemia Patients With Central Nervous System Involvement From Clinical Trials: an Analysis of the National ...)
Dahniel Sastow , Douglas Tremblay, Marina Kremyanskaya & John Mascarenhas
7/11/23
1 item of Media coverage
Press/Media
-
FDA Approves Momelotinib (Ojjaara) for Myelofibrosis Patients With Anemia
20/09/23
1 item of Media coverage
Press/Media